Extra lymph node removal in left lung cancer surgery
Part of Cancer, Lungs & breathing clinical trials.
This trial compares two ways of doing lung cancer surgery for early-stage tumors in the left lung. Some participants will have more lymph nodes removed (station 4L) and others will not, to see if the extra removal helps prevent the cancer from coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between the ages of 18 and 75.
- You have a single, solid lump (nodule) in your left lung that is confirmed to be cancer.
- Your cancer is early stage (stage 1), meaning the tumor is no larger than 4 cm and hasn't spread to lymph nodes or other organs.
- You are scheduled for surgery to remove the part of the lung with the tumor (segmentectomy or lobectomy) along with lymph nodes.
- You have not had lung surgery before, and you have not had radiation or chemotherapy for this cancer.
- You have no other cancer history.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of surgery for small, early-stage lung cancers that are deep inside the lung. It aims to see if removing only a small part of the lung (segmentectomy) works as well as removing a whole lobe (lobectomy), which may help patients recover faster and preserve more lung function.
This trial tests how well a computer model predicts which lymph nodes need to be removed during lung cancer surgery. If you have early-stage lung cancer that can be removed, you may be eligible.
This study compares two surgical approaches for removing early-stage lung cancer (2-3 cm) from the outer part of the lung. It aims to see if removing only the affected segment (segmentectomy) is as effective as removing a larger portion of the lung (lobectomy), while potentially preserving more lung function.
This trial compares removing fewer lymph nodes during surgery for early-stage non-small cell lung cancer. It is for people with a small tumor (2 cm or less) that has both solid and ground-glass parts.
This study looks at whether removing lymph nodes from the opposite side of the chest during surgery can help people with advanced lung cancer that has spread to the lymph nodes in the middle of the chest. It may offer a more thorough treatment for patients who are healthy enough for surgery.
This trial tests whether a more focused lymph node removal during surgery is safe and effective for people with a small, early-stage lung cancer (non-small cell type) located in the top part of the lung (apical segment).
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.